1.Mayalarp SP, Hargreaves RH, Butler J, O'Hare CC, Hartley JA.. (1996) Cross-linking and sequence specific alkylation of DNA BY aziridinylquinones. 1. Quinone methides., 39 (2):[PMID:8558523][10.1021/jm950629q]
2.Moret EE, de Boer M, Hilbers HW, Tollenaere JP, Janssen LH, Holthuis JJ, Driebergen RJ, Verboom W, Reinhoudt DN.. (1996) In vivo activity and hydrophobicity of cytostatic aziridinyl quinones., 39 (3):[PMID:8576915][10.1021/jm9405147]
3.Kumar S, Malachowski WP, DuHadaway JB, LaLonde JM, Carroll PJ, Jaller D, Metz R, Prendergast GC, Muller AJ.. (2008) Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors., 51 (6):[PMID:18318466][10.1021/jm7014155]
4.De Rosa S, De Giulio A, Iodice C.. (1994) Biological effects of prenylated hydroquinones: structure-activity relationship studies in antimicrobial, brine shrimp, and fish lethality assays., 57 (12):[PMID:7714539][10.1021/np50114a015]
6.Bremer PT, Hixon MS, Janda KD.. (2014) Benzoquinones as inhibitors of botulinum neurotoxin serotype A., 22 (15):[PMID:24984937][10.1016/j.bmc.2014.06.004]
7.Johnson-Ajinwo OR, Ullah I, Mbye H, Richardson A, Horrocks P, Li WW.. (2018) The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents., 28 (7):[PMID:29519737][10.1016/j.bmcl.2018.02.051]
8.Calil FA, David JS, Chiappetta ERC, Fumagalli F, Mello RB, Leite FHA, Castilho MS, Emery FS, Nonato MC.. (2019) Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase., 167 [PMID:30776695][10.1016/j.ejmech.2019.02.018]